The reiteration of a Buy rating and maintenance of an $80 price target by a reputable analyst firm like HC Wainwright & Co. could positively influence investor sentiment towards Celldex Therapeutics. This endorsement reaffirms the firm's confidence in the company's prospects, potentially leading to increased investor interest and a positive short-term impact on the stock price.